2007
Willingness to pay for drug rehabilitation: Implications for cost recovery
Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, Havens JR, Latkin CA, Strathdee SA. Willingness to pay for drug rehabilitation: Implications for cost recovery. Journal Of Health Economics 2007, 27: 959-972. PMID: 18207264, PMCID: PMC2601723, DOI: 10.1016/j.jhealeco.2007.11.007.Peer-Reviewed Original ResearchMeSH KeywordsAdultFemaleFinancing, PersonalHumansInterviews as TopicMaleMiddle AgedPatient Acceptance of Health CareRehabilitationSubstance-Related DisordersCost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs
Sindelar JL, Olmstead TA, Peirce JM. Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs. Addiction 2007, 102: 1463-1471. PMID: 17645428, PMCID: PMC3072844, DOI: 10.1111/j.1360-0443.2007.01913.x.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisCounselingFemaleHumansMaleMethadoneNarcoticsPatient Acceptance of Health CareRewardSubstance-Related DisordersTreatment OutcomeConceptsPrize-based contingency managementUsual careContingency managementStimulant-negative urine samplesUrine samplesNational Drug Abuse Treatment Clinical Trials NetworkTreatment programMethadone maintenance treatment programIncremental costBaseline urine samplesMulti-site clinical trialMaintenance treatment programMethadone maintenance clinicsClinical Trials NetworkCommunity treatment programsCost-effectiveness studiesCost of treatmentCost-effectiveness analysisPresence of stimulantsCM conditionClinical trialsCommunity clinicsMaintenance clinicsEffectiveness trialTreatment outcomes
2006
Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs
Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug And Alcohol Dependence 2006, 87: 175-182. PMID: 16971054, PMCID: PMC1950254, DOI: 10.1016/j.drugalcdep.2006.08.012.Peer-Reviewed Original ResearchConceptsUsual careStimulant abusersClinical trialsPatient outcomesNational Drug Abuse Treatment Clinical Trials NetworkDrug abuse treatment clinicsAbstinence-based incentivesIncremental cost-effectiveness ratioUsual care groupPrimary patient outcomeRandomized clinical trialsClinical Trials NetworkPsychosocial treatment programCost-effectiveness ratioCost-effectiveness analysisCare groupTreatment clinicsStimulant abstinenceAcceptability curvesAbstinence timeTreatment programTrials NetworkIncremental costCareIncentive group